De Novo Status Epilepticus in patients with COVID-19.
Sana SomaniSandipan PatiTyler GastonAlissa ChitlangiaShruti AgnihotriPublished in: Annals of clinical and translational neurology (2020)
Neurological complications are increasingly recognized with SARS-CoV-2, the causative pathogen for COVID-19. We present a single-center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African-American women with laboratory-confirmed SARS-CoV-2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID-19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment.
Keyphrases
- sars cov
- african american
- case report
- respiratory syndrome coronavirus
- coronavirus disease
- mental health
- working memory
- risk factors
- cross sectional
- squamous cell carcinoma
- emergency department
- candida albicans
- functional connectivity
- radiation therapy
- brain injury
- community dwelling
- rectal cancer
- locally advanced
- replacement therapy
- high density